The Efficacy and Safety of Anlotinib in Pediatric Patients With Refractory or Recurrent Solid Tumors by Suying Lu, Suying Lu, Ye Hong, Ye Hong, Huimou Chen, Huimou Chen, Liuhong Wu, Liuhong Wu, Feifei Sun, Feifei Sun, Juan Wang, Juan Wang, Jia Zhu, Jia Zhu, Yi Que, Yi Que, Lian Zhang, Lian Zhang, Zijun Zhen, Zijun Zhen, Xiaofei Sun, Xiaofei Sun, Junting Huang, Junting Huang, Yizhuo Zhang, Yizhuo Zhang

Connect to this object online.

Efficacy, safety, and cost-effectiveness of pegylated PEG-rhg-CSF in pediatric patients receiving high-intensity chemotherapy: results from a phase II study by Junting Huang, Jia Zhu, Lian Jiang, Jiaqian Xu, Xiheng Lin, Jian Chang, Xiaohong Zhang, Suying Lu, Feifei Sun, Juan Wang, Yi Que, Zhonglv Ye, Lihua Yang, Xiuli Yuan, Weisong Cai, Chuan Tian, Yanpeng Wu, Xiangling He, Yan-Lai Tang, Yizhuo Zhang

Connect to this object online.